SCHEMBL29979098

SCHEMBL29979098

Cc1c([C@@]2(CNC(=O)OC(C)(C)C)NC(=O)NC2=O)ncn1C

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADAMTS7 Q9UKP4 7/20 0.38
MMP13 P45452 6/20 0.37
MMP14 P50281 6/20 0.37
ADAMTS5 Q9UNA0 6/20 0.37
ADAMTS4 O75173 5/20 0.37
MMP2 P08253 5/20 0.37
MMP3 P08254 5/20 0.37
ADAM17 P78536 5/20 0.37
MMP1 P03956 3/20 0.37
MMP7 P09237 3/20 0.37
MMP9 P14780 3/20 0.37
KDM4E B2RXH2 2/20 0.34
LMNA P02545 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
ALDH1A1 P00352 1/20 0.33
GFER P55789 1/20 0.33
NSD2 O96028 1/20 0.33
MAPT P10636 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23354516 1.00 ADAMTS7 (0.38) ADAMTS7MMP13MMP14ADAMTS5ADAMTS4
SCHEMBL24927868 0.86 ADAMTS7 (0.38) ADAMTS7MMP13MMP14ADAMTS5ADAMTS4
SCHEMBL29978955 0.86 ADAMTS7 (0.38) ADAMTS7MMP13MMP14ADAMTS5ADAMTS4
SCHEMBL23361642 0.85 ADAMTS4 (0.39) ADAMTS7MMP13MMP14ADAMTS5ADAMTS4
SCHEMBL23366860 0.81 ADAMTS7 (0.55) ADAMTS7MMP13MMP14ADAMTS5ADAMTS4
SCHEMBL29873669 0.81 ADAMTS7 (0.55) ADAMTS7MMP13MMP14ADAMTS5ADAMTS4
SCHEMBL29873851 0.80 ADAMTS7 (0.54) ADAMTS7MMP13MMP14ADAMTS5ADAMTS4
SCHEMBL23371296 0.80 ADAMTS7 (0.54) ADAMTS7MMP13MMP14ADAMTS5ADAMTS4
SCHEMBL23354518 0.80 ADAMTS7 (0.36) ADAMTS7MMP13MMP14ADAMTS5ADAMTS4
SCHEMBL24927728 0.80 ADAMTS7 (0.40) ADAMTS7MMP13MMP14ADAMTS5ADAMTS4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12398120-B2 Substituted hydantoinamides as ADAMTS7 antagonists BAYER AKTIENGESELLSCHAFT (DE) 2025-08-26 US disclosed
EP-4058448-B1 HYDANTOIN DERIVATIVES AS ADAMTS7 ANTAGONISTS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BAYER AG (DE) 2024-05-29 EP disclosed
US-20230027346-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS BAYER AKTIENGESELLSCHAFT (DE) 2023-01-26 US disclosed
EP-4058448-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS Bayer Aktiengesellschaft (DE) 2022-09-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12398120-B2 Substituted hydantoinamides as ADAMTS7 antagonists ADAMTS7, MMP7, ADAM17 ADAMTS7 1/4885MMP13 55/4885MMP14 80/4885
US-20230027346-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS ADAMTS7, MMP7, ADAM17 ADAMTS7 1/4885MMP13 55/4885MMP14 80/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.